Brief: Marker Therapeutics Inc Files For Offer And Sale Of Up To 25.8 Million Shares Of Common Stock By Lincoln Park Capital Fund - SEC Filing
23/12/2022 14:02
Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS INC FILES FOR OFFER AND SALE OF UP TO
25.8
MILLION SHARES OF COMMON STOCK BY LINCOLN PARK CAPITAL FUND -
SEC FILING
Source text for Eikon: ID:
Further company coverage: MRKR.O
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79